Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 5/20 | 0.59 |
| ▸ | CES2 | O00748 | 2/20 | 0.59 |
| ▸ | CES1 | P23141 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.45 |
| ▸ | DAO | P14920 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.43 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1667152 | 0.91 | TDP1 (0.67) | SRCTDP1L3MBTL1LMNACES2 | |
| SCHEMBL29586362 | 0.88 | TDP1 (0.64) | SRCTDP1L3MBTL1LMNACES2 | |
| SCHEMBL28025801 | 0.88 | TDP1 (0.64) | SRCTDP1L3MBTL1LMNACES2 | |
| SCHEMBL2122042 | 0.86 | SRC (0.57) | SRCTDP1L3MBTL1LMNACES2 | |
| SCHEMBL9356311 | 0.86 | SRC (0.52) | SRCTDP1L3MBTL1LMNACES2 | |
| SCHEMBL8990032 | 0.84 | TDP1 (0.59) | SRCTDP1L3MBTL1LMNACES2 | |
| SCHEMBL148725 | 0.83 | SRC (1.00) | SRCTDP1L3MBTL1LMNACES2 | |
| SCHEMBL70165 | 0.83 | SRC (1.00) | SRCTDP1L3MBTL1LMNACES2 | |
| SCHEMBL23457197 | 0.83 | TDP1 (0.57) | SRCTDP1L3MBTL1LMNACES2 | |
| SCHEMBL600680 | 0.83 | TDP1 (0.57) | SRCTDP1L3MBTL1LMNACES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105339445-B | Industrial deinking of ink compositions | 西康制造有限公司 | 2019-07-05 | — | — | CN | claimed |
| CN-105339445-A | Industrial deinking of ink compositions | XEIKON IP BV | 2016-02-17 | — | — | CN | claimed |
| EP-0326915-B1 | A LOCALLY ADMINISTRABLE THERAPEUTIC COMPOSITION FOR INFLAMMATORY DISEASE | Senju Pharmaceutical Co., Ltd. (JP) | 1992-09-02 | — | — | EP | claimed |
| US-4910225-A | Benzoylphenylacetic acid | SENJU PHARMACEUTICAL CO., LTD. (JP) | 1990-03-20 | — | — | US | claimed |
| EP-0326915-A1 | A locally administrable therapeutic composition for inflammatory disease | Senju Pharmaceutical Co., Ltd. (JP) | 1989-08-09 | — | — | EP | claimed |
| US-3962303-A | Novel benzoylphenylacetic acid derivatives | ROUSSEL-UCLAF (FR) | 1976-06-08 | — | — | US | claimed |
| US-3931286-A | Novel benzoylphenylacetic acid derivatives | ROUSSEL-UCLAF (FR) | 1976-01-06 | — | — | US | claimed |
| JP-2124817-A | — | — | None | — | — | JP | disclosed |
| CN-115279206-A | Flavor composition | 弗门尼舍有限公司 | 2022-11-01 | — | — | CN | disclosed |
| WO-2020231796-A1 | FLEXIBLE SUBSTRATE, METHOD FOR THE MANUFACTURE THEREOF, AND FLEXIBLE ELECTRONIC ASSEMBLIES COMPRISING THE FLEXIBLE SUSBTRATE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2020-11-19 | — | — | WO | disclosed |
| US-20200360326-A1 | Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid | BAUSCH & LOMB INCORPORATED | 2020-11-19 | — | — | US | disclosed |
| EP-3738994-A1 | FLEXIBLE SUBSTRATE, METHOD FOR THE MANUFACTURE THEREOF, AND FLEXIBLE ELECTRONIC ASSEMBLIES COMPRISING THE FLEXIBLE SUSBTRATE | SABIC Global Technologies B.V. (NL) | 2020-11-18 | — | — | EP | disclosed |
| US-10646435-B2 | Pasty bio-adhesive sustained release compositions | CARE & PHARMA PERSPECTIVES SA (CH) | 2020-05-12 | — | — | US | disclosed |
| US-3975531-A | ANTIINFLAMMATORY | A. H. ROBINS COMPANY, INCORPORATED (US) | 1976-08-17 | — | — | US | disclosed |
| US-3962303-A | Novel benzoylphenylacetic acid derivatives | ROUSSEL-UCLAF (FR) | 1976-06-08 | — | — | US | disclosed |
| US-3962303-A | Novel benzoylphenylacetic acid derivatives | ROUSSEL-UCLAF (FR) | 1976-06-08 | — | — | US | disclosed |
| US-3962303-A | Novel benzoylphenylacetic acid derivatives | ROUSSEL-UCLAF (FR) | 1976-06-08 | — | — | US | disclosed |
| US-3931286-A | Novel benzoylphenylacetic acid derivatives | ROUSSEL-UCLAF (FR) | 1976-01-06 | — | — | US | disclosed |
| US-3931286-A | Novel benzoylphenylacetic acid derivatives | ROUSSEL-UCLAF (FR) | 1976-01-06 | — | — | US | disclosed |
| US-3931286-A | Novel benzoylphenylacetic acid derivatives | ROUSSEL-UCLAF (FR) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200360326-A1 | Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid | AADAT, UACA, IL4 | SRC 3535/4885TDP1 3215/4885L3MBTL1 4813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.